MIRA PHARMACEUTICALS, INC.
MIRANasdaqHealthcare · Pharmaceutical Preparations · FL · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Operating income | — | — | — | — |
| Net income | −$10.4M | −$7.9M | −$12.0M | −$7.1M |
| Total assets | $11.1M | $2.9M | $4.9M | $858,074 |
| Total liabilities | $702,068 | $723,349 | $558,097 | $1.5M |
| Equity | $10.4M | $2.2M | $4.4M | −$596,232 |
| EPS (diluted) | $-1.35 | $-0.51 | $-0.85 | $-0.40 |
| Shares out. | 16.8M | 14.8M | 14.8M | 13.3M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- —
- Return on equity
- −100.5%
- Return on assets
- −94.1%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 6.3%
- Debt / equity
- 0.07×
- Book value / share
- $0.62
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Accruals / assets
- −52.1%clean
- Piotroski F-Score
- 4/7mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 warning● 2 good- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Shekhat Denil NanjiDirector | Oct 1, 2025 | Grant | 22,378 | $1.35 |
| Aminov ErezOfficer — Chief Executive Officer | Oct 1, 2025 | Grant | 2.7M | — |
| Aminov ErezOfficer — Chief Executive Officer | Aug 29, 2025 | Grant | 62,500 | $1.37 |
| Aminov ErezOfficer — Chief Executive Officer | Nov 19, 2024 | Sell | 55,410 | $1.39 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 408,157 | 3.7 | -1.0% |
| Apr 30, 2026 | 412,249 | 2.3 | +8.9% |
| Apr 15, 2026 | 378,494 | 2.5 | -13.4% |
| Mar 31, 2026 | 437,032 | 2.4 | +31.6% |
| Mar 13, 2026 | 332,123 | 2.0 | -32.1% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Regulation FD disclosureMay 27, 2026
- Regulation FD disclosureMay 13, 2026
- Other material eventMay 13, 2026
- Other material eventMar 23, 2026
- Other material eventMar 3, 2026
- Other material eventFeb 2, 2026
- Director / officer changeDec 22, 2025
- Other material eventDec 5, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.